Skip to main content

Published locations for Ibrutinib response durable at 1 year in CLL patients who relapsed after allogeneic stem cell transplants

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ibrutinib response durable at 1 year in CLL patients who relapsed after allogeneic stem cell transplants

User login

  • Reset your password
  • /content/ibrutinib-response-durable-1-year-cll-patients-who-relapsed-after-allogeneic-stem-cell
  • /hematologynews/article/105756/cll/ibrutinib-response-durable-1-year-cll-patients-who-relapsed-after
  • /oncologypractice/article/105756/cll/ibrutinib-response-durable-1-year-cll-patients-who-relapsed
  • /hematology-oncology/article/105756/cll/ibrutinib-response-durable-1-year-cll-patients-who-relapsed
  • /b-cell-lymphoma-icymi/article/105756/cll/ibrutinib-response-durable-1-year-cll-patients-who-relapsed